Login
Products
Login
Home
Alerts
Search
Watchlist
Products

TCM Ltd

TCMLMTD
BSE
44.27
3.66%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

TCM Ltd

TCMLMTD
BSE
44.27
3.66%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
33Cr
Close
Close Price
44.27
Industry
Industry
Food - Processing - Others
PE
Price To Earnings
PS
Price To Sales
1.47
Revenue
Revenue
22Cr
Rev Gr TTM
Revenue Growth TTM
-16.62%
PAT Gr TTM
PAT Growth TTM
-89.35%
Peer Comparison
How does TCMLMTD stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
TCMLMTD
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
5751195768366
Growth YoY
Revenue Growth YoY%
261.01,075.8394.11,330.475.0-27.636.9-45.3-10.9-39.2-14.2-7.9
Expenses
ExpensesCr
6871196778576
Operating Profit
Operating ProfitCr
-1-1-21-1-1-1-10-2-1-1
OPM
OPM%
-15.5-9.9-32.56.9-7.7-19.7-8.4-9.60.8-61.1-14.0-9.7
Other Income
Other IncomeCr
000000004010
Interest Expense
Interest ExpenseCr
000000000011
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-1-1-210-1-1-14-2-1-1
Tax
TaxCr
000000000000
PAT
PATCr
-1-1-210-1-1-14-2-1-1
Growth YoY
PAT Growth YoY%
73.531.9-171.9149.357.3-41.663.2-230.4957.5-115.6-29.7-31.1
NPM
NPM%
-22.4-10.6-34.56.1-5.5-20.6-9.3-14.652.7-73.2-14.0-20.7
EPS
EPS
-1.4-0.9-2.21.0-0.5-1.3-0.8-1.25.4-3.0-1.1-1.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
01447322622
Growth
Revenue Growth%
132.3361.8-16.4106.7338.7-19.3-13.6
Expenses
ExpensesCr
125811342826
Operating Profit
Operating ProfitCr
-1-1-1-4-4-2-2-3
OPM
OPM%
-248.9-91.1-21.1-112.8-50.0-7.0-8.3-14.6
Other Income
Other IncomeCr
011-20045
Interest Expense
Interest ExpenseCr
00000012
Depreciation
DepreciationCr
00000000
PBT
PBTCr
-100-6-4-210
Tax
TaxCr
00000000
PAT
PATCr
-100-6-4-210
Growth
PAT Growth%
132.1-61.1-5,065.527.346.4161.1-123.6
NPM
NPM%
-239.333.12.8-165.4-58.1-7.15.4-1.5
EPS
EPS
-1.70.90.2-9.4-6.0-2.62.2-0.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
33337777
Reserves
ReservesCr
2929292223212320
Current Liabilities
Current LiabilitiesCr
1713151719364749
Non Current Liabilities
Non Current LiabilitiesCr
20202020202008
Total Liabilities
Total LiabilitiesCr
6965686169847683
Current Assets
Current AssetsCr
95659454264
Non Current Assets
Non Current AssetsCr
6060625759383420
Total Assets
Total AssetsCr
6965686169847683

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-2-10-4-112-10
Investing Cash Flow
Investing Cash FlowCr
00-146-10
Financing Cash Flow
Financing Cash FlowCr
5-3005-110
Net Cash Flow
Net Cash FlowCr
4-400000
Free Cash Flow
Free Cash FlowCr
-2-10-1-131-11
CFO To PAT
CFO To PAT%
172.2-187.6327.171.6254.4-85.1-720.2
CFO To EBITDA
CFO To EBITDA%
165.668.2-43.2105.0295.6-86.9466.1

Ratios

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1601416254127
Price To Earnings
Price To Earnings
0.00.0114.30.00.00.016.6
Price To Sales
Price To Sales
40.60.03.24.73.41.31.0
Price To Book
Price To Book
0.50.00.40.70.81.40.9
EV To EBITDA
EV To EBITDA
-18.1-6.7-21.6-5.7-7.1-18.2-17.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
-6.729.155.826.721.027.930.1
OPM
OPM%
-248.9-91.1-21.1-112.8-50.0-7.0-8.3
NPM
NPM%
-239.333.12.8-165.4-58.1-7.15.4
ROCE
ROCE%
-2.50.80.8-18.4-12.5-7.34.7
ROE
ROE%
-2.90.90.4-23.2-13.9-8.04.6
ROA
ROA%
-1.40.50.2-9.6-6.2-2.71.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
TCM Limited is an Indian multi-sector conglomerate currently undergoing a strategic transformation. Historically a chemical manufacturer, the company has successfully pivoted into a diversified holding structure with interests spanning **Real Estate Development**, **Agribusiness**, **Renewable Energy**, **Healthcare Diagnostics**, and **EdTech**. The company is focused on unlocking value from its legacy land bank to fuel expansion into high-growth, technology-driven sectors. --- ### **Strategic Pivot & Asset Monetization Framework** TCM Limited is executing a structured transition from legacy manufacturing to a diversified operational model. The core of this strategy involves the monetization of non-productive assets to fund new ventures. * **Kalamassery Land Development:** The company successfully resolved a long-standing liability with **Godrej Properties Limited** in March 2025, paying **₹15.01 Crore** to discharge a charge on its **11-acre** land bank. This has paved the way for a Joint Venture with **Asset Homes** to develop residential villas and flats. * **Debt Resolution & Bridge Financing:** To facilitate clear titles for development, the company secured a **₹25 Crore** loan from **Asset Homes TCM Townships Pvt Ltd**. * **Asset Divestments:** The company is aggressively offloading non-core holdings: * Reclassified land in **Ulundurpet** and **Mettur** (carrying value **₹1,970.34 Lakhs**) as **Assets held-for-sale**. * Sold a portion of the **Ulundurpet** land for **₹60 Lakhs** in early 2025. * Authorized the sale of **7.064 acres** in **Tuticorin, Tamil Nadu**. * **Recurring Income Generation:** In November 2024, the company reclassified **₹519.81 Lakhs** of inventory to **Investment Property**. This includes **11,382 Sq Ft** of commercial space at the **Hi-Lite building, Maradu**, leased to **Indus Towers Limited** for nearly **9 years**. --- ### **Segmented Business Operations** The Group manages its operations through four distinct reportable segments, showing significant revenue volatility as it scales new verticals. | Segment | FY 2024-25 (₹ Lakhs) | FY 2023-24 (₹ Lakhs) | FY 2022-23 (₹ Lakhs) | | :--- | :---: | :---: | :---: | | **Manufacturing** | **1,087.21** | **1,245.62** | **64.19** | | **Real Estate** | **713.57** | **94.92** | **-** | | **Trading** | **671.96** | **1,824.19** | **650.26** | | **Educational** | **127.87** | **58.46** | **20.31** | | **Total Revenue** | **2,600.61** | **3,223.19** | **734.76** | #### **1. Agribusiness & Manufacturing** This is currently the largest revenue contributor. The company produces **cattle and poultry feed**. * **Expansion:** Leased a **10,760 Sq Ft** factory in Palakkad (September 2025). * **Acquisition:** Signed a binding MoU to acquire **100%** of **Better Feeds Private Limited** for **₹7.65 Crore**. * **Contract Manufacturing:** Entered an MoU with **Biogenix Inc Pvt Ltd** (May 2024) for diagnostic reagents. #### **2. Healthcare Diagnostics (fluorecare Platform)** Operated via **TCM Healthcare Private Limited**, the company provides a **Quantitative Point-of-Care Testing (POCT)** platform using **Immunofluorescence** technology. * **Diagnostic Scope:** Covers Tumor Markers (CEA, PSA), Cardiac Markers (Troponin, D-dimer), Diabetes (HbA1c), and Thyroid profiles. * **Hardware Ecosystem:** Includes the **T 25 Digital Dry Block Incubator**, **SMD-01 Vortex Mixer**, and **HM-01 Hematology Blood Mixer**. * **Infrastructure:** Opened a new **1,621 Sq Ft** Healthcare Division office in Ernakulam in November 2025. #### **3. Renewable Energy & Trading** Through **TCM Solar Private Limited**, the company focuses on the installation and commissioning of **Solar Power Plants**. The trading arm also manages medical diagnostics, autocare, and audio products. #### **4. EdTech & AI Learning** Operated through **iSpark Learning Solutions (76.01% stake)**, this segment focuses on e-learning platforms integrated with **Artificial Intelligence**. --- ### **Financial Profile & Capital Structure** TCM has stabilized its balance sheet through equity infusion and strategic reclassifications. * **Equity Base:** Total equity stood at **₹3,784.23 Lakhs** as of March 2025. A prior **Rights Issue** raised **₹10.20 Crore** at **₹25 per share**, with promoters converting **₹5 Crore** of debt into equity. * **Profitability:** Recorded a Net Profit After Tax of **₹3.26 Crore** on a turnover of **₹29.51 Crore** in FY25. * **One-time Gains:** Recorded a **₹420.77 Lakhs** liability write-back in FY25 following the Kalamassery land settlement. * **Borrowing Profile:** * **Fixed Rate Exposure:** Increased to **₹1,109.15 Lakhs** (March 2025), primarily vehicle and equipment loans (**7.5% - 12.3% p.a.**). * **Liquidity:** Utilizes interest-free, repayable-on-demand loans from directors and an overdraft facility (at **11.90%**) secured by land. --- ### **Risk Management & Governance** The company operates under a Board-led risk framework to manage its multi-sector exposure. * **Concentration Risk:** A single customer accounted for over **10%** of total revenue in FY25, indicating a need for client diversification. * **Credit & Liquidity:** Uses **Ind AS 109 ECL models** to manage trade receivables (typically **30–180 days**). The company relies on holding company support for short-term liquidity. * **Operational Risks:** Identified **Revenue Recognition (cut-off risk)** as a Key Audit Matter due to diverse regional delivery timelines. * **Regulatory/Labor Risks:** Recently transitioned to formal actuarial valuations for gratuity. The company settled a long-standing dispute with Mettur division employees for **₹69.36 Lakhs** (including interest). * **Market Risk:** While the company imports healthcare equipment, it currently reports **zero unhedged foreign currency exposure**. It uses **Level 1 derivatives** to manage gold and forex price fluctuations when necessary. --- ### **Subsidiary Ecosystem** | Entity | Ownership | Focus Area | | :--- | :---: | :--- | | **TCM Healthcare Pvt Ltd** | **100%** | Diagnostic equipment and reagents | | **TCM Solar Pvt Ltd** | **100%** | Renewable energy projects | | **TCM Properties Pvt Ltd** | **100%** | Infrastructure and township development | | **iSpark Learning Solutions** | **76.01%** | AI-based EdTech platforms |